629
Views
8
CrossRef citations to date
0
Altmetric
Short Communications

Clinical CVVH model removes endothelium-derived microparticles from circulation

, , , , , , & show all
Article: 23498 | Received 12 Mar 2013, Accepted 02 Jul 2014, Published online: 27 Feb 2014

References

  • Bernard GR, Artigas A, Brigham KL, Carlet J, Falke K, Hudson L et al. The American–European Consensus Conference on ARDS. Definitions, mechanisms, relevant outcomes, and clinical trial coordination. Am J Respir Crit Care Med. 1994; 149: 818–24.
  • Rubenfeld GD, Caldwell E, Peabody E, Weaver J, Martin DP, Neff M et al. Incidence and outcomes of acute lung injury. N Engl J Med. 2005; 353: 1685–93.
  • Ashbaugh DG, Bigelow DB, Petty TL, Levine BE. Acute respiratory distress in adults. Lancet. 1967; 2: 319–23.
  • Goss CH, Brower RG, Hudson LD, Rubenfeld GD. Incidence of acute lung injury in the United States. Crit Care Med. 2003; 31: 1607–11.
  • Buesing KL, Densmore JC, Kaul S, Pritchard KA Jr., Jarzembowski JA, Gourlay DM et al. Endothelial microparticles induce inflammation in acute lung injury. J Surg Res. 2011; 166: 32–9.
  • Densmore JC, Signorino PR, Ou J, Hatoum OA, Rowe JJ, Shi Y et al. Endothelium-derived microparticles induce endothelial dysfunction and acute lung injury. Shock. 2006; 26: 464–71.
  • Agouni A, Lagrue-Lak-Hal AH, Ducluzeau PH, Mostefai HA, Draunet-Busson C, Leftheriotis G et al. Endothelial dysfunction caused by circulating microparticles from patients with metabolic syndrome. Am J Pathol. 2008; 173: 1210–9.
  • Blann A, Shantsila E, Shantsila A. Microparticles and arterial disease. Semin Thromb Hemost. 2009; 35: 488–96.
  • Forest A, Pautas E, Ray P, Bonnet D, Verny M, Amabile N et al. Circulating microparticles and procoagulant activity in elderly patients. J Gerontol A Biol Sci Med Sci. 2010; 65: 414–20.
  • Guiducci S, Distler JH, Jungel A, Huscher D, Huber LC, Michel BA et al. The relationship between plasma microparticles and disease manifestations in patients with systemic sclerosis. Arthritis Rheum. 2008; 58: 2845–53.
  • Kang P, Shen B, Yang J, Pei F. Circulating platelet-derived microparticles and endothelium-derived microparticles may be a potential cause of microthrombosis in patients with osteonecrosis of the femoral head. Thromb Res. 2008; 123: 367–73.
  • Morel O, Ohlmann P, Epailly E, Bakouboula B, Zobairi F, Jesel L et al. Endothelial cell activation contributes to the release of procoagulant microparticles during acute cardiac allograft rejection. J Heart Lung Transplant. 2008; 27: 38–45.
  • Ogura H, Tanaka H, Koh T, Fujita K, Fujimi S, Nakamori Y et al. Enhanced production of endothelial microparticles with increased binding to leukocytes in patients with severe systemic inflammatory response syndrome. J Trauma. 2004; 56: 823–30. discussion 30–1.
  • van Beers EJ, Schaap MC, Berckmans RJ, Nieuwland R, Sturk A, van Doormaal FF et al. Circulating erythrocyte-derived microparticles are associated with coagulation activation in sickle cell disease. Haematologica. 2009; 94: 1513–9.
  • Amabile N, Guerin AP, Leroyer A, Mallat Z, Nguyen C, Boddaert J et al. Circulating endothelial microparticles are associated with vascular dysfunction in patients with end-stage renal failure. J Am Soc Nephrol. 2005; 16: 3381–8.
  • Amabile N, Heiss C, Chang V, Angeli FS, Damon L, Rame EJ et al. Increased CD62e(+) endothelial microparticle levels predict poor outcome in pulmonary hypertension patients. J Heart Lung Transplant. 2009; 28: 1081–6.
  • Amabile N, Heiss C, Real WM, Minasi P, McGlothlin D, Rame EJ et al. Circulating endothelial microparticle levels predict hemodynamic severity of pulmonary hypertension. Am J Respir Crit Care Med. 2008; 177: 1268–75.
  • Arteaga RB, Chirinos JA, Soriano AO, Jy W, Horstman L, Jimenez JJ et al. Endothelial microparticles and platelet and leukocyte activation in patients with the metabolic syndrome. Am J Cardiol. 2006; 98: 70–4.
  • Bakouboula B, Morel O, Faure A, Zobairi F, Jesel L, Trinh A et al. Procoagulant membrane microparticles correlate with the severity of pulmonary arterial hypertension. Am J Respir Crit Care Med. 2008; 177: 536–43.
  • Bandi VD, Munnur U, Matthay MA. Acute lung injury and acute respiratory distress syndrome in pregnancy. Crit Care Clin. 2004; 20: 577–607.
  • Bastarache JA, Fremont RD, Kropski JA, Bossert FR, Ware LB. Procoagulant alveolar microparticles in the lungs of patients with acute respiratory distress syndrome. Am J Physiol Lung Cell Mol Physiol. 2009; 297: L1035–41.
  • Bernard S, Loffroy R, Serusclat A, Boussel L, Bonnefoy E, Thevenon C et al. Increased levels of endothelial microparticles CD144 (VE-Cadherin) positives in type 2 diabetic patients with coronary noncalcified plaques evaluated by multidetector computed tomography (MDCT). Atherosclerosis. 2009; 203: 429–35.
  • Boulanger CM, Amabile N, Guerin AP, Pannier B, Leroyer AS, Mallat CN et al. In vivo shear stress determines circulating levels of endothelial microparticles in end-stage renal disease. Hypertension. 2007; 49: 902–8.
  • Boulanger CM, Scoazec A, Ebrahimian T, Henry P, Mathieu E, Tedgui A et al. Circulating microparticles from patients with myocardial infarction cause endothelial dysfunction. Circulation. 2001; 104: 2649–52.
  • Bretelle F, Sabatier F, Desprez D, Camoin L, Grunebaum L, Combes V et al. Circulating microparticles: a marker of procoagulant state in normal pregnancy and pregnancy complicated by preeclampsia or intrauterine growth restriction. Thromb Haemost. 2003; 89: 486–92. [PubMed Abstract].
  • Brodsky SV, Facciuto ME, Heydt D, Chen J, Islam HK, Kajstura M et al. Dynamics of circulating microparticles in liver transplant patients. J Gastrointestin Liver Dis. 2008; 17: 261–8. [PubMed Abstract].
  • Brogan PA, Shah V, Brachet C, Harnden A, Mant D, Klein N et al. Endothelial and platelet microparticles in vasculitis of the young. Arthritis Rheum. 2004; 50: 927–36.
  • Bulut D, Maier K, Bulut-Streich N, Borgel J, Hanefeld C, Mugge A. Circulating endothelial microparticles correlate inversely with endothelial function in patients with ischemic left ventricular dysfunction. J Card Fail. 2008; 14: 336–40.
  • Carp H, Dardik R, Lubetsky A, Salomon O, Eskaraev R, Rosenthal E et al. Prevalence of circulating procoagulant microparticles in women with recurrent miscarriage: a case-controlled study. Hum Reprod. 2004; 19: 191–5.
  • Chironi GN, Boulanger CM, Simon A, Dignat-George F, Freyssinet JM, Tedgui A. Endothelial microparticles in diseases. Cell Tissue Res. 2009; 335: 143–51.
  • Cocucci E, Racchetti G, Meldolesi J. Shedding microvesicles: artefacts no more. Trends Cell Biol. 2009; 19: 43–51.
  • Combes V, Coltel N, Faille D, Wassmer SC, Grau GE. Cerebral malaria: role of microparticles and platelets in alterations of the blood–brain barrier. Int J Parasitol. 2006; 36: 541–6.
  • Combes V, Simon AC, Grau GE, Arnoux D, Camoin L, Sabatier F et al. In vitro generation of endothelial microparticles and possible prothrombotic activity in patients with lupus anticoagulant. J Clin Invest. 1999; 104: 93–102.
  • Combes V, Taylor TE, Juhan-Vague I, Mege JL, Mwenechanya J, Tembo M et al. Circulating endothelial microparticles in malawian children with severe falciparum malaria complicated with coma. JAMA. 2004; 291: 2542–4. [PubMed Abstract].
  • Dignat-George F, Camoin-Jau L, Sabatier F, Arnoux D, Anfosso F, Bardin N et al. Endothelial microparticles: a potential contribution to the thrombotic complications of the antiphospholipid syndrome. Thromb Haemost. 2004; 91: 667–73. [PubMed Abstract].
  • Dursun I, Poyrazoglu HM, Gunduz Z, Ulger H, Yykylmaz A, Dusunsel R et al. The relationship between circulating endothelial microparticles and arterial stiffness and atherosclerosis in children with chronic kidney disease. Nephrol Dial Transplant. 2009; 24: 2511–8.
  • Erdbruegger U, Grossheim M, Hertel B, Wyss K, Kirsch T, Woywodt A et al. Diagnostic role of endothelial microparticles in vasculitis. Rheumatology (Oxford). 2008; 47: 1820–5.
  • Esposito K, Ciotola M, Giugliano F, Sardelli L, Maiorino MI, Beneduce F et al. Phenotypic assessment of endothelial microparticles in diabetic and nondiabetic men with erectile dysfunction. J Sex Med. 2008; 5: 1436–42.
  • Esposito K, Ciotola M, Giugliano F, Schisano B, Improta L, Improta MR et al. Endothelial microparticles correlate with erectile dysfunction in diabetic men. Int J Impot Res. 2007; 19: 161–6.
  • Esposito K, Ciotola M, Schisano B, Gualdiero R, Sardelli L, Misso L et al. Endothelial microparticles correlate with endothelial dysfunction in obese women. J Clin Endocrinol Metab. 2006; 91: 3676–9.
  • Faure V, Dou L, Sabatier F, Cerini C, Sampol J, Berland Y et al. Elevation of circulating endothelial microparticles in patients with chronic renal failure. J Thromb Haemost. 2006; 4: 566–73.
  • Gelderman MP, Schiffmann R, Simak J. Elevated endothelial microparticles in Fabry children decreased after enzyme replacement therapy. Arterioscler Thromb Vasc Biol. 2007; 27: e138–9.
  • Gonzalez-Quintero VH, Jimenez JJ, Jy W, Mauro LM, Hortman L, O'Sullivan MJ et al. Elevated plasma endothelial microparticles in preeclampsia. Am J Obstet Gynecol. 2003; 189: 589–93.
  • Gonzalez-Quintero VH, Smarkusky LP, Jimenez JJ, Mauro LM, Jy W, Hortsman LL et al. Elevated plasma endothelial microparticles: preeclampsia versus gestational hypertension. Am J Obstet Gynecol. 2004; 191: 1418–24.
  • Jimenez JJ, Jy W, Mauro LM, Horstman LL, Ahn YS. Elevated endothelial microparticles in thrombotic thrombocytopenic purpura: findings from brain and renal microvascular cell culture and patients with active disease. Br J Haematol. 2001; 112: 81–90.
  • Jimenez JJ, Jy W, Mauro LM, Horstman LL, Bidot CJ, Ahn YS. Endothelial microparticles (EMP) as vascular disease markers. Adv Clin Chem. 2005; 39: 131–57. [PubMed Abstract].
  • Kumpers P, Erdbrugger U, Grossheim M, Meyer GP, Hiss M, Gwinner W et al. Endothelial microparticles as a diagnostic aid in Churg-Strauss vasculitis-induced cardiomyopathy. Clin Exp Rheumatol. 2008; 26(3 Suppl 49): S86–9. [PubMed Abstract].
  • Mallat Z, Benamer H, Hugel B, Benessiano J, Steg PG, Freyssinet JM et al. Elevated levels of shed membrane microparticles with procoagulant potential in the peripheral circulating blood of patients with acute coronary syndromes. Circulation. 2000; 101: 841–3.
  • Martinez MC, Tesse A, Zobairi F, Andriantsitohaina R. Shed membrane microparticles from circulating and vascular cells in regulating vascular function. Am J Physiol Heart Circ Physiol. 2005; 288: H1004–9.
  • Nomura S, Inami N, Shouzu A, Urase F, Maeda Y. Correlation and association between plasma platelet-, monocyte- and endothelial cell-derived microparticles in hypertensive patients with type 2 diabetes mellitus. Platelets. 2009; 20: 406–14.
  • Pihusch V, Rank A, Steber R, Pihusch M, Pihusch R, Toth B et al. Endothelial cell-derived microparticles in allogeneic hematopoietic stem cell recipients. Transplantation. 2006; 81: 1405–9.
  • Pirro M, Schillaci G, Bagaglia F, Menecali C, Paltriccia R, Mannarino MR et al. Microparticles derived from endothelial progenitor cells in patients at different cardiovascular risk. Atherosclerosis. 2008; 197: 757–67.
  • Shantsila E. Endothelial microparticles: a universal marker of vascular health?. J Hum Hypertens. 2009; 23: 359–61.
  • Shet AS, Aras O, Gupta K, Hass MJ, Rausch DJ, Saba N et al. Sickle blood contains tissue factor-positive microparticles derived from endothelial cells and monocytes. Blood. 2003; 102: 2678–83.
  • Simak J, Gelderman MP, Yu H, Wright V, Baird AE. Circulating endothelial microparticles in acute ischemic stroke: a link to severity, lesion volume and outcome. J Thromb Haemost. 2006; 4: 1296–302.
  • Simak J, Holada K, Risitano AM, Zivny JH, Young NS, Vostal JG. Elevated circulating endothelial membrane microparticles in paroxysmal nocturnal haemoglobinuria. Br J Haematol. 2004; 125: 804–13.
  • Vanwijk MJ, Svedas E, Boer K, Nieuwland R, Vanbavel E, Kublickiene KR. Isolated microparticles, but not whole plasma, from women with preeclampsia impair endothelium-dependent relaxation in isolated myometrial arteries from healthy pregnant women. Am J Obstet Gynecol. 2002; 187: 1686–93.
  • Werner N, Wassmann S, Ahlers P, Kosiol S, Nickenig G. Circulating CD31+/annexin V+ apoptotic microparticles correlate with coronary endothelial function in patients with coronary artery disease. Arterioscler Thromb Vasc Biol. 2006; 26: 112–6.
  • Jimenez JJ, Jy W, Mauro LM, Soderland C, Horstman LL, Ahn YS. Endothelial cells release phenotypically and quantitatively distinct microparticles in activation and apoptosis. Thromb Res. 2003; 109: 175–80.
  • Sander TL, Ou JS, Densmore JC, Kaul S, Matus I, Twigger S et al. Protein composition of plasminogen activator inhibitor type 1-derived endothelial microparticles. Shock. 2008; 29: 504–11.
  • Klinkner DB, Densmore JC, Kaul S, Noll L, Lim HJ, Weihrauch D et al. Endothelium-derived microparticles inhibit human cardiac valve endothelial cell function. Shock. 2006; 25(6): 575–80.
  • National Heart L, Blood Institute Acute Respiratory Distress Syndrome Clinical Trials N, Wiedemann HP, Wheeler AP, Bernard GR, Thompson BT et al. Comparison of two fluid-management strategies in acute lung injury. N Engl J Med. 2006; 354: 2564–75.
  • Prowle JR, Echeverri JE, Ligabo EV, Ronco C, Bellomo R. Fluid balance and acute kidney injury. Nat Rev Nephrol. 2010; 6: 107–15.
  • Su X, Bai C, Hong Q, Zhu D, He L, Wu J et al. Effect of continuous hemofiltration on hemodynamics, lung inflammation and pulmonary edema in a canine model of acute lung injury. Intensive Care Med. 2003; 29: 2034–42.
  • Ullrich R, Roeder G, Lorber C, Quezado ZM, Kneifel W, Gasser H et al. Continuous venovenous hemofiltration improves arterial oxygenation in endotoxin-induced lung injury in pigs. Anesthesiology. 2001; 95: 428–36.
  • Elbahlawan L, West NK, Avent Y, Cheng C, Liu W, Barfield RC et al. Impact of continuous renal replacement therapy on oxygenation in children with acute lung injury after allogeneic hematopoietic stem cell transplantation. Pediatr Blood Cancer. 2010; 55: 540–5.
  • Yan XW, Li WQ, Wang H, Zhang ZH, Li N, Li JS. Effects of high-volume continuous hemofiltration on experimental pancreatitis associated lung injury in pigs. Int J Artif Organs. 2006; 29: 293–302. [PubMed Abstract].
  • Chon GR, Chang JW, Huh JW, Lim CM, Koh Y, Park SK et al. A comparison of the time from sepsis to inception of continuous renal replacement therapy versus RIFLE criteria in patients with septic acute kidney injury. Shock. 2012; 38: 30–6.